These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 172473)

  • 41. Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
    Dölken G; Klein G
    Virology; 1976 Mar; 70(1):210-3. PubMed ID: 176804
    [No Abstract]   [Full Text] [Related]  

  • 42. Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
    Hampar B; Derge JG; Nonoyama M; Chang SY; Tagamets A; Showalter SD
    Virology; 1974 Nov; 62(1):71-89. PubMed ID: 4371498
    [No Abstract]   [Full Text] [Related]  

  • 43. Epstein-Barr virus-regulation studies on somatic-cell hybrids derived from the fusion of Burkitt's lymphoma and nasopharyngeal carcinoma cells with human or mouse partners.
    Klein G
    IARC Sci Publ (1971); 1978; (20):369-76. PubMed ID: 215519
    [No Abstract]   [Full Text] [Related]  

  • 44. Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections.
    Orellana T; Kieff E
    J Virol; 1977 May; 22(2):321-30. PubMed ID: 194056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus carried by Raji cells: a mutant in early functions?
    Kallin B; Klein G
    Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon and natural killing of human lymphoma cell lines after induction of the Epstein Barr viral cycle by superinfection.
    Blazar BA; Strome M; Schooley R
    J Immunol; 1984 Feb; 132(2):816-20. PubMed ID: 6197476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus: detection of genome in somatic cell hybrids of Burkitt lymphoblastoid cells.
    Glaser R; Nonoyama M
    Science; 1973 Feb; 179(4072):492-3. PubMed ID: 4350214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of protease inhibitors on the activation of Epstein-Barr virus repressed in cultured lymphoid cells.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1981; 16(1):49-52. PubMed ID: 6276326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of dibutyryl cyclic AMP on the induction of Epstein-Barr virus in hybrid cells.
    Zimmerman JE; Glaser R; Rapp F
    J Virol; 1973 Dec; 12(6):1442-5. PubMed ID: 4357515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
    Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
    Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
    [No Abstract]   [Full Text] [Related]  

  • 51. Epstein-Barr virus-associated antigens in non-producing clones of human lymphoblastoid cell lines.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1972 Oct; 239(95):242-3. PubMed ID: 4343346
    [No Abstract]   [Full Text] [Related]  

  • 52. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suitability of Epstein-Barr virus DNA obtained from superinfected Raji cells for complementary RNA hybridization studies.
    Tanaka A
    J Gen Virol; 1977 Feb; 34(2):375-9. PubMed ID: 190349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G
    J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour-promoting phorbol esters inhibit DNA synthesis and enhance virus-induced interferon production in a human lymphoma cell line.
    Adolf GR; Swetly P
    J Gen Virol; 1980 Nov; 51(Pt 1):61-7. PubMed ID: 6161998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers.
    Lvovsky E; Levine PH; Fuccillo D; Ablashi DV; Bengali ZH; Armstrong GR; Levy HB
    J Natl Cancer Inst; 1981 Jun; 66(6):1013-9. PubMed ID: 6165852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosome banding, isoenzyme studies and determination of Epstein-Barr virus DNA content on human Burkitt lymphoma/mouse hybrids.
    Spira J; Povey S; Wiener F; Klein G; Andersson-Anvret M
    Int J Cancer; 1977 Dec; 20(6):849-53. PubMed ID: 201572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity to EBV superinfection and IUdR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line.
    Nyormoi O; Klein G; Adams A; Dombos L
    Int J Cancer; 1973 Sep; 12(2):396-408. PubMed ID: 4365093
    [No Abstract]   [Full Text] [Related]  

  • 60. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.